Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neutra AZ
- Development stage
- Unknown
- Lead developer
- Symbion Life Science
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Neutra AZ is an oral dietary supplement developed and marketed by Symbion Life Science. It is formulated as a tablet containing a combination of multivitamins (including ascorbic acid, nicotinamide, folic acid, pyridoxine, calcium pantothenate, riboflavin, thiamine, biotin, and methylcobalamin), multiminerals, and grape seed extract. Neutra AZ is utilized as supportive care, particularly for oncology patients, to help maintain physical and mental well-being, manage fatigue, and reduce chemotherapy-induced neuropathy by addressing nutritional deficiencies and providing antioxidant support.
- Brand names
- Neutra AZ
- Other names
- Neutra AZ Grape Seed ExtractNeutra AZ Tablet
Beyond the preview
Go deeper on Neutra AZ.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neutra AZ.